RAFFERTY ASSET MANAGEMENT, LLC – Neurocrine Biosciences, Inc. Transaction History
RAFFERTY ASSET MANAGEMENT, LLC portfolio value:
$6.91M
portfolio value
RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +61.20% | 24.72K shares | 2.97M | $106.21 | 65.12K |
| Q2 2022 | share | Decrease | -32.55% | -19.49K shares | -1.67M | $97.48 | 40.40K |
| Q1 2022 | share | Decrease | -9.52% | -6.30K shares | -23K | $93.75 | 59.89K |
| Q4 2021 | share | Increase | +105.50% | 33.98K shares | 2.54M | $84.63 | 66.2K |
| Q3 2021 | share | Increase | +21.79% | 5.76K shares | 516K | $95.91 | 32.21K |
| Q2 2021 | share | Decrease | -22.97% | -7.88K shares | -765K | $97.32 | 26.45K |
| Q1 2021 | share | Increase | +232.26% | 24.00K shares | 2.34M | $97.25 | 34.33K |
| Q4 2020 | share | Decrease | -47.72% | -9.43K shares | -910K | $95.85 | 10.33K |
| Q3 2020 | share | Increase | +77.35% | 8.62K shares | 541K | $96.16 | 19.76K |
| Q2 2020 | share | Increase | +160.34% | 6.86K shares | 989K | $122 | 11.14K |
| Q1 2020 | share | Decrease | -87.98% | -31.33K shares | -3.45M | $86.55 | 4.28K |
| Q4 2019 | share | Decrease | -47.04% | -31.62K shares | -2.23M | $107.49 | 35.61K |
| Q3 2019 | share | Increase | +14.13% | 8.32K shares | 1.08M | $90.11 | 67.24K |
| Q2 2019 | share | Decrease | -8.70% | -5.61K shares | -710K | $84.43 | 58.91K |
| Q1 2019 | share | Increase | 0.00% | 64.53K shares | 5.68M | $88.1 | 64.53K |